FRAMINGHAM, Mass., May 30, 2023 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today released its 2022 sustainability report. The first annual report highlights Definitive Healthcare’s success in environmental, social, and governance practices. It also outlines social responsibility goals for 2023 to build on the established progress.
“Operating responsibly, being transparent with our various stakeholders, and being good corporate citizens within the local and global communities in which we operate are core to our values as a company,” said Robert Musslewhite, CEO of Definitive Healthcare. “Creating a sustainable business is not only the key to our success as an organization, but it’s the right thing to do for the good of our planet.”
For the inaugural report, Definitive Healthcare prioritized sustainability topics most important to its business, stakeholders, and growth, including the recruitment and management of a global, diverse, and inclusive workforce, privacy and data protection, and energy and emissions. As a result of the company’s ESG efforts in 2022, ISS ESG recognized Definitive Healthcare with “Prime” status, indicating the company was within the top 10% of issuers within the health care technology and services industry.
Some of Definitive Healthcare’s 2022 ESG achievements highlighted in the report include:
To learn more about Definitive Healthcare’s commitment to sustainability, please download the Sustainability Report.
About Definitive Healthcare
At Definitive Healthcare, our passion is to transform data, analytics, and expertise into healthcare commercial intelligence. We help clients uncover the right markets, opportunities, and people, so they can shape tomorrow’s healthcare industry. Our SaaS platform creates new paths to commercial success in the healthcare market, so companies can identify where to go next. Learn more at definitivehc.com.
Media Contacts:
Danielle Johns
This email address is being protected from spambots. You need JavaScript enabled to view it.
Highwire PR
This email address is being protected from spambots. You need JavaScript enabled to view it.
Investor Relations Contact:
Brian Denyeau
ICR for Definitive Healthcare
This email address is being protected from spambots. You need JavaScript enabled to view it.
646-277-1251
Last Trade: | US$4.19 |
Daily Change: | 0.02 0.36 |
Daily Volume: | 432,704 |
Market Cap: | US$449.220M |
February 27, 2025 February 25, 2025 November 07, 2024 October 10, 2024 |
Amneal Pharmaceuticals is a fully-integrated essential medicines company. We make healthy possible through the development, manufacturing, and distribution of generic and specialty pharmaceuticals. The Company has a diverse portfolio of over 250 products in its Generics segment and is expanding across...
CLICK TO LEARN MORERecursion Pharmaceuticals is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously expands one of the world’s largest....
CLICK TO LEARN MOREEnd of content
No more pages to load